Reports for NAPROXEN
Ingredient
NAPROXEN
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-NAPROXEN | 375MG | TABLET | Resolved | 2018-11-30 | 2018-12-21 | 68228 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2018-12-12 | 2018-12-21 | 69312 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2020-01-22 | 2020-02-21 | 103914 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2020-02-05 | 2020-02-21 | 105352 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2021-02-05 | 2021-03-30 | 133385 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2021-02-19 | 2021-03-17 | 134439 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2021-06-04 | 2021-06-22 | 140420 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2022-09-01 | 2022-11-20 | 168421 |
APO-NAPROXEN | 375MG | TABLET | Resolved | 2023-09-07 | 2023-10-13 | 203849 |
TEVA-NAPROXEN | 250MG | TABLET | Resolved | 2020-04-03 | 2020-05-08 | 110749 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-NAPROXEN EC | Discontinued | 2017-08-24 | 2017-08-24 | 20189 | ||
PMS-NAPROXEN | 500MG | SUPPOSITORY | Discontinued | 2020-06-15 | 2021-10-27 | 117745 |
APO-NAPROXEN | 250MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4734 |
APO-NAPROXEN | 250MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60666 |
TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
NAPROXEN-375 | 375MG | TABLET | Discontinued | 2024-06-17 | 2024-06-27 | 230710 |
NAPROXEN - 250 | 250MG | TABLET | Discontinued | 2024-06-17 | 2024-06-27 | 230707 |
NAPROXEN - 500 | 500MG | TABLET | Discontinued | 2024-06-17 | 2024-06-27 | 230716 |
APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
NAPROSYN | 375MG | TABLET (ENTERIC-COATED) | Discontinued | 2024-07-10 | 2024-08-01 | 232646 |